Pradaxa Capsules 110mg, manufactured by Nippon Boehringer Ingelheim, contain dabigatran etexilate methanesulfonate, an anticoagulant that prevents blood clots, thereby reducing the risk of stroke and systemic embolism. The YJ code is 3339001M2020, and the standard is 110mg 1 capsule.
Pradaxa Capsules 110mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →